scPharmaceuticals Inc

(NASDAQ:SCPH)

Latest On scPharmaceuticals Inc (SCPH):

Date/Time Type Description Signal Details
2023-05-20 04:36 ESTNewsscPharmaceuticals: Furoscix Firing On All Cylinders In Q1, Bullish Than EverN/A
2023-05-11 10:11 ESTNewsscPharmaceuticals Inc. (SCPH) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 20:15 ESTNewsscPharmaceuticals GAAP EPS of -$0.28 beats by $0.08, revenue of $2.1M beats by $0.53MN/A
2023-03-28 11:24 ESTNewsscPharmaceuticals: Furoscix Launch And Market Access; A Promising OutlookN/A
2023-03-24 00:13 ESTNewsscPharmaceuticals stock surges ~20% amid Q4 results with eye on Furoscix future revenueN/A
2023-03-23 07:35 ESTNewsscPharmaceuticals Inc. (SCPH) Q4 2022 Earnings Call TranscriptN/A
2023-03-22 16:56 ESTNewsscPharmaceuticals GAAP EPS of -$0.27 beats by $0.12N/A
2023-01-24 19:16 ESTNewsscPharmaceuticals: Undervalued, De-Risked Cardiology Commercial Biotech, Initiating With A BuyN/A
2022-12-20 00:16 ESTNewsscPharmaceuticals names Rachael Nokes as CFON/A
2022-11-22 07:31 ESTNewsscPharmaceuticals announces stock offeringN/A
2022-11-13 04:21 ESTNewsscPharmaceuticals Inc. (SCPH) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 05:26 ESTNewsscPharmaceuticals GAAP EPS of -$0.37, guidance loweredN/A
2022-10-20 05:52 ESTNewsscPharmaceuticals: Furoscix Approval A Potential Paradigm Shift For Heart Failure PatientsN/A
2022-10-11 20:12 ESTNewsscPharmaceuticals: Not All Approvals Cause A Stock To Go UpN/A
2022-10-10 16:52 ESTNewsFDA approves scPharmaceuticals Furoscix to treat congestion in heart failureN/A
2022-08-10 05:21 ESTNewsscPharmaceuticals GAAP EPS of -$0.35 misses by $0.05N/A
2022-07-12 14:52 ESTNewsscPharma says key goals in mid-stage study favored heart failure therapyN/A
2022-05-16 18:42 ESTNewsscPharmaceuticals gains as FDA accepts marketing application for heart failure drugN/A
2022-05-16 18:42 ESTNewsscPharmaceuticals GAAP EPS of -$0.26N/A
2022-04-12 16:51 ESTNewsscPharmaceuticals refiles for FDA approval of Furoscix for heart failureN/A
2022-03-23 12:25 ESTNewsscPharmaceuticals GAAP EPS of -$0.27 beats by $0.08N/A
2021-11-09 16:26 ESTNewsscPharmaceuticals EPS misses by $0.01N/A
2021-08-26 19:31 ESTNewsscPharmaceuticals: We Still See A High Probability Of Success For FUROSCIXN/A
2021-08-11 07:37 ESTNewsscPharmaceuticals EPS misses by $0.06N/A
2021-07-21 23:02 ESTNewsscPharmaceuticals perks up on positive data for FUROSCIX in heart failure studyN/A
2021-03-23 09:30 ESTNewsscPharmaceuticals EPS misses by $0.22N/A
2021-03-16 21:58 ESTAnalyst RatingThe Analyst Target Price has increased from $11 to $12.Buy
2021-02-27 01:19 ESTNewsscPharmaceuticals (SCPH) Presents At SVB Leerink 10th Annual Global Healthcare Conference - SlideshowN/A
2021-02-23 20:30 ESTNewsscPharmaceuticals reports FDA meeting results regarding Furoscix applicationN/A
2021-01-15 15:17 ESTNewsscPharmaceuticals Inc.: The FUROSCIX CRLs Have Created An Excellent Buying OpportunityN/A
2020-12-09 05:15 ESTAnalyst RatingThe Analyst Target Price has decreased from $12 to $11.Neutral
2020-12-08 05:14 ESTAnalyst RatingThe Analyst Target Price has decreased from $13.75 to $12.Neutral
2020-12-07 09:42 ESTNewsFDA rejects scPharma's Furoscix application, againN/A
2020-12-01 13:03 ESTAnalyst RatingThe Analyst Target Price has increased from $13.5 to $13.75.Buy
2020-11-26 21:29 ESTFinancialsCompany financials have been released.Neutral
2020-11-20 21:01 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 21:09 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 18:56 ESTNewsscPharmaceuticals EPS beats by $0.05N/A
2020-11-17 05:21 ESTEarnings EstimateAn EPS average of -$0.46 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-08 00:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:05 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 14:37 ESTAnalyst RatingThe Analyst Target Price has increased from $13.25 to $13.5.Buy
2020-09-26 13:59 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:12 ESTFinancialsCompany financials have been released.Neutral
2020-08-22 09:02 ESTNewsScPharma inks supply agreement with West PharmaN/A
2020-08-15 13:40 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 17:37 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 10:04 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 02:15 ESTNewsscPharmaceuticals EPS beats by $0.03N/A
2020-08-06 21:49 ESTFinancialsCompany financials have been released.Neutral

About scPharmaceuticals Inc (SCPH):

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.

SCPH Quotes by TradingView

See Advanced Chart

General

  • Name scPharmaceuticals Inc
  • Symbol SCPH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 26
  • Fiscal Year EndDecember
  • IPO Date2017-11-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.scpharmaceuticals.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.15
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.46
  • Return on Assets -22%
  • Return on Equity -48%
  • Earnings Per Share -$1.45
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 190.15 million
  • EBITDA -25816000
  • Analyst Target Price $12
  • Book Value Per Share $3.29
View More

Share Statistics

  • Shares Outstanding 27.32 million
  • Shares Float 8.2 million
  • % Held by Insiders 851%
  • % Held by Institutions 65.77%
  • Shares Short 309510
  • Shares Short Prior Month 300460
  • Short Ratio 3.44
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.41
  • 52 Week High $11.99
  • 52 Week Low $5
  • 50 Day Moving Average 7.11
  • 200 Day Moving Average 7.46
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

scPharmaceuticals Inc (SCPH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

scPharmaceuticals Inc (SCPH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$0.33-$0.3711.6%
2020-06-302020-08-13$N/A-$0.36-$0.4213.61%
2020-03-312020-05-12$N/A-$0.35-$0.5435.19%
2019-12-312020-03-24$N/A-$0.58-$0.52-12.25%
2019-09-302019-11-12$N/A-$0.33-$0.4220.81%
2019-06-302019-08-07$N/A-$0.39-$0.4920.41%
2019-03-312019-05-08$N/A-$0.47-$0.494.08%
2018-12-312019-03-21$N/A-$0.27-$0.4539.33%
2018-09-302018-11-13$N/A-$0.31-$0.5442.06%
2018-06-302018-08-14$N/A-$0.53-$0.576.19%
2018-03-312018-05-07$N/A-$0.47-$0.506%
2017-12-312018-03-20$N/A-$0.46-$0.519.22%
2017-09-302017-11-17$N/A-$0.30

scPharmaceuticals Inc (SCPH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A 4.15 million 8.32 million 4.29 million
Income Before Tax N/A N/A -7.09 million -10.81 million -6.21 million
Selling General Administrative N/A N/A 2.5 million 2.12 million 2 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A N/A -6.36 million -10.43 million -6.29 million
Operating Income N/A N/A -6.65 million -10.43 million -6.29 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A -31000 -381000 82000
Net Income From Continuing Operations N/A N/A -7.09 million -10.81 million -6.21 million
Net Income Applicable to Common Shares -9.04 million -8.3 million N/A -10.81 million -6.21 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities 1.28 million 1.03 million N/A N/A N/A
Total Cash Flow from Investing Activities -29.69 million -40.47 million N/A N/A N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A 49.95 million 10.46 million N/A N/A
Change to Operating Activities 1.93 million 461000 N/A N/A N/A
Change in Cash N/A 3.52 million 2.72 million N/A N/A
Total Cash from Operating Activities -4.81 million -5.96 million -7.74 million N/A N/A
Depreciation N/A 99000 95000 N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A -800000 N/A N/A N/A
Change to Net Income 924000 745000 N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A 25.38 million N/A N/A
Total Stockholder Equity N/A N/A 55.1 million 57.89 million N/A
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets N/A N/A 80.49 million N/A N/A
Common Stock N/A N/A N/A N/A N/A
Other Current Assets N/A N/A 59000 N/A N/A
Retained Earnings N/A N/A -136.55 million N/A N/A
Other Liabilities N/A N/A N/A N/A N/A
Other Assets N/A N/A N/A N/A N/A
Cash N/A N/A 75.34 million N/A N/A
Total Current Liabilities N/A N/A 4.66 million N/A N/A
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment N/A N/A N/A N/A N/A
Total Current Assets N/A N/A 79.07 million N/A N/A
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 98.06 million 55.1 million N/A 57.89 million N/A
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A 19 million N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable N/A N/A 652000 N/A N/A

scPharmaceuticals Inc (SCPH) Chart:

scPharmaceuticals Inc (SCPH) News:

Below you will find a list of latest news for scPharmaceuticals Inc (SCPH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

scPharmaceuticals Inc (SCPH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.53.7CALL0 0458.55TRUE00
2024-05-1750.3CALL34 248123.07FALSE0.30
2024-05-177.50.05CALL0 890FALSE00
2024-05-17100.2CALL0 150FALSE00
2024-05-1712.50.05CALL0 5010FALSE00
2024-05-17150.12CALL0 460FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750.6PUT0 24185.72TRUE00
2024-05-177.52.95PUT0 10452.49TRUE00
2024-05-17100PUT0 0561.94TRUE00
2024-05-1712.50PUT0 0433.08TRUE00
2024-05-17150PUT0 0459.36TRUE00
2024-06-212.50CALL0 0391.49TRUE00
2024-06-2150CALL0 081.34FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 080.18TRUE00
2024-06-217.50PUT0 0239.35TRUE00
2024-08-162.52.3CALL0 14167.91TRUE00
2024-08-1650.8CALL0 5776.44FALSE00
2024-08-167.50.27CALL0 160FALSE00
2024-08-16100.16CALL0 1000FALSE00
2024-08-162.50PUT0 00FALSE00
2024-08-1650.55PUT0 10TRUE00
2024-08-167.50PUT0 077.18TRUE00
2024-08-16100PUT0 0181.43TRUE00
2024-11-152.50CALL0 0252.75TRUE00
2024-11-1550CALL0 068.86FALSE00
2024-11-157.50.45CALL0 60FALSE00
2024-11-15100CALL0 00FALSE00
2024-11-152.50PUT0 00FALSE00
2024-11-1550PUT0 00TRUE00
2024-11-157.52.16PUT0 178.76TRUE00
2024-11-15100PUT0 0130.31TRUE00
2024-12-202.53.1CALL0 8102.15TRUE00
2024-12-2051.25CALL0 4166.21FALSE00
2024-12-207.50.45CALL0 66569.39FALSE00
2024-12-20100.25CALL150 19979.35FALSE0.250
2024-12-2012.50.4CALL0 1170FALSE00
2024-12-202.50.27PUT0 250FALSE00
2024-12-2051PUT0 26571.89TRUE00
2024-12-207.50PUT0 079.91TRUE00
2024-12-20105PUT0 2688.98TRUE00
2024-12-2012.50PUT0 0172.23TRUE00

Latest SCPH Trades:

Date Shares Price
Jun 13, 2022 5:26 PM EST14$4.49
Jun 13, 2022 5:38 PM EST14$4.49
Jun 13, 2022 5:59 PM EST14$4.49
Jun 13, 2022 7:48 PM EST10$4.515
Jun 13, 2022 7:59 PM EST100$4.43

scPharmaceuticals Inc (SCPH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320018277/0000899243-20-018277-index.htm
2019-02-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1604950/000000000019001629/0000000000-19-001629-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027190/0000899243-17-027190-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027196/0000899243-17-027196-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027197/0000899243-17-027197-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027198/0000899243-17-027198-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027200/0000899243-17-027200-index.htm
2017-11-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027203/0000899243-17-027203-index.htm
2017-11-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027391/0000899243-17-027391-index.htm
2017-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317029322/0000899243-17-029322-index.htm
2018-01-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318001522/0000899243-18-001522-index.htm
2018-01-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318001523/0000899243-18-001523-index.htm
2018-01-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318001525/0000899243-18-001525-index.htm
2018-02-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318003707/0000899243-18-003707-index.htm
2018-06-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017623/0000899243-18-017623-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017624/0000899243-18-017624-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017630/0000899243-18-017630-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017632/0000899243-18-017632-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017633/0000899243-18-017633-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017634/0000899243-18-017634-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017635/0000899243-18-017635-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017636/0000899243-18-017636-index.htm
2018-07-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318020520/0000899243-18-020520-index.htm
2018-07-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318020521/0000899243-18-020521-index.htm
2018-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318020522/0000899243-18-020522-index.htm
2018-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318020523/0000899243-18-020523-index.htm
2019-03-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319006445/0000899243-19-006445-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017634/0000899243-19-017634-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017635/0000899243-19-017635-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017637/0000899243-19-017637-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017638/0000899243-19-017638-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017639/0000899243-19-017639-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017642/0000899243-19-017642-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017643/0000899243-19-017643-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017644/0000899243-19-017644-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319029406/0000899243-19-029406-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320001192/0000899243-20-001192-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320001194/0000899243-20-001194-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016162/0000899243-20-016162-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016163/0000899243-20-016163-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016164/0000899243-20-016164-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016165/0000899243-20-016165-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016166/0000899243-20-016166-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016167/0000899243-20-016167-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016168/0000899243-20-016168-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016169/0000899243-20-016169-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320018277/0000899243-20-018277-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320018996/0000899243-20-018996-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320019000/0000899243-20-019000-index.htm
2017-12-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000094787117000981/0000947871-17-000981-index.htm
2018-01-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000094787118000064/0000947871-18-000064-index.htm
2020-03-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000094787120000300/0000947871-20-000300-index.htm
2020-05-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000094787120000512/0000947871-20-000512-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000094787120000513/0000947871-20-000513-index.htm
2017-12-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000110465917071638/0001104659-17-071638-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000110465920021904/0001104659-20-021904-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000110465920022837/0001104659-20-022837-index.htm
2020-02-214/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000110465920023928/0001104659-20-023928-index.htm
2020-03-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000110465920041157/0001104659-20-041157-index.htm
2020-06-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000110465920069253/0001104659-20-069253-index.htm
2017-11-27SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000114420417060942/0001144204-17-060942-index.htm
2017-12-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000114420417063136/0001144204-17-063136-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000114420419019689/0001144204-19-019689-index.htm
2018-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000119312518042997/0001193125-18-042997-index.htm
2018-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518089540/0001193125-18-089540-index.htm
2018-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518154480/0001193125-18-154480-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518179561/0001193125-18-179561-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518191084/0001193125-18-191084-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518194510/0001193125-18-194510-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518197936/0001193125-18-197936-index.htm
2018-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518224769/0001193125-18-224769-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518247916/0001193125-18-247916-index.htm
2018-08-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1604950/000119312518260582/0001193125-18-260582-index.htm
2018-09-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518269246/0001193125-18-269246-index.htm
2018-10-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518301489/0001193125-18-301489-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518303628/0001193125-18-303628-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518324899/0001193125-18-324899-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518335203/0001193125-18-335203-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519001554/0001193125-19-001554-index.htm
2019-01-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1604950/000119312519001560/0001193125-19-001560-index.htm
2019-01-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1604950/000119312519001570/0001193125-19-001570-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519019764/0001193125-19-019764-index.htm
2019-02-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1604950/000119312519031002/0001193125-19-031002-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519081494/0001193125-19-081494-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519140543/0001193125-19-140543-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519165105/0001193125-19-165105-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519177625/0001193125-19-177625-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519214672/0001193125-19-214672-index.htm
2019-08-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604950/000119312519228020/0001193125-19-228020-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519228026/0001193125-19-228026-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519247390/0001193125-19-247390-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519289319/0001193125-19-289319-index.htm
2020-03-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000119312520082513/0001193125-20-082513-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520083166/0001193125-20-083166-index.htm
2020-03-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1604950/000119312520083819/0001193125-20-083819-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520139772/0001193125-20-139772-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604950/000119312520147282/0001193125-20-147282-index.htm
2020-05-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604950/000119312520149176/0001193125-20-149176-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520149214/0001193125-20-149214-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520165709/0001193125-20-165709-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520190819/0001193125-20-190819-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520199136/0001193125-20-199136-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520218282/0001193125-20-218282-index.htm
2020-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520225629/0001193125-20-225629-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000120919120032809/0001209191-20-032809-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000120919120032812/0001209191-20-032812-index.htm
2018-03-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1604950/000156459018006366/0001564590-18-006366-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1604950/000156459018009817/0001564590-18-009817-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1604950/000156459018009832/0001564590-18-009832-index.htm
2018-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459018011269/0001564590-18-011269-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459018021584/0001564590-18-021584-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459018029140/0001564590-18-029140-index.htm
2019-03-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/0001564590-19-008726-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1604950/000156459019014297/0001564590-19-014297-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1604950/000156459019014307/0001564590-19-014307-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459019017242/0001564590-19-017242-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459019030027/0001564590-19-030027-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459019042889/0001564590-19-042889-index.htm
2020-03-2410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1604950/000156459020012500/0001564590-20-012500-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1604950/000156459020018809/0001564590-20-018809-index.htm
2020-04-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1604950/000156459020018811/0001564590-20-018811-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459020024648/0001564590-20-024648-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459020039992/0001564590-20-039992-index.htm
2019-02-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1604950/999999999519000164/9999999995-19-000164-index.htm

scPharmaceuticals Inc (SCPH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of scPharmaceuticals Inc (SCPH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 851%
Institutional Ownership: 6577%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-21ORBIMED ADVISORS LLC10% Share HolderBuy231,200.008.651,999,880.00231,200.00https://www.sec.gov/Archives/edgar/data/1604950/000094787120000513/0000947871-20-000513-index.htm
2017-11-21Invest A/S Lundbeckfond10% Share HolderBuy654,762.0014.009,166,668.003,183,986.00https://www.sec.gov/Archives/edgar/data/1604950/000089924317027197/0000899243-17-027197-index.htm
2020-02-14RA CAPITAL MANAGEMENT, L.P.10% Share HolderBuy271,993.008.202,230,342.603,247,005.00https://www.sec.gov/Archives/edgar/data/1604950/000110465920022837/0001104659-20-022837-index.htm
2019-04-11RA CAPITAL MANAGEMENT, LLC10% Share HolderBuy389,862.002.701,052,627.403,247,005.00https://www.sec.gov/Archives/edgar/data/1604950/000114420419019689/0001144204-19-019689-index.htm
2017-11-21PHARMACEUTICAL INDUSTRIES LTD SUN10% Share HolderBuy357,143.0014.005,000,002.00357,143.00https://www.sec.gov/Archives/edgar/data/1604950/000089924317027391/0000899243-17-027391-index.htm
2020-05-21ORBIMED ADVISORS LLC10% Share HolderBuy1,156,083.008.6510,000,117.954,565,948.00https://www.sec.gov/Archives/edgar/data/1604950/000094787120000513/0000947871-20-000513-index.htm
2020-06-30John H TuckerPresident and CEOBuy42,250.0047,250.00https://www.sec.gov/Archives/edgar/data/1604950/000089924320018277/0000899243-20-018277-index.htm
2019-12-13John H TuckerPresident and CEOBuy5,000.005.2426,188.505,000.00https://www.sec.gov/Archives/edgar/data/1604950/000089924319029406/0000899243-19-029406-index.htm
2017-12-19LEONARD D SCHAEFFERDirectorBuy22,631.001.6637,567.4657,449.00https://www.sec.gov/Archives/edgar/data/1604950/000089924317029322/0000899243-17-029322-index.htm
2020-05-26Andrew J. Schwab10% Share HolderBuy578,034.008.654,999,994.10578,034.00https://www.sec.gov/Archives/edgar/data/1604950/000120919120032812/0001209191-20-032812-index.htm